Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Kaye

Showing results (261-270 of 411) with videos related to

Pageof 42
Sort By:
British Journal of Cancer|August 17, 2000
Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT)J S de Bono, J Paul, A Simpson, et al.
Biochemical Pharmacology|January 20, 1994
Identification of a multidrug resistance modulator with clinical potential by analysis of synergistic activity in vitro, toxicity in vivo and growth delay in a solid human tumour xenograftJ A Plumb, G C Wishart, A Setanoians, et al.
British Journal of Cancer|April 17, 1999
In pursuit of excellence for patients with cancer: the Scottish Cancer Therapy Network modelP L Stroner, D H Brewster, J A Dewar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1992
Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working PartyG Read, S P Stenning, M H Cullen, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1988
Pharmacokinetics of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum IV (iproplatinum, CHIP) in patients with normal and impaired renal function and following intraperitoneal administrationD J Kerr, M Harding, J G Farmer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1992
High-dose epirubicin in chemotherapy refractory non-seminomatous germ cell cancer: a phase II study. EORTC Genito-Urinary Tract Cancer Co-operative Group. EORTC Early Clinical Trials GroupG Stoter, A Akdas, S D Fosså, et al.
British Journal of Cancer|November 1, 1995
Phase II trials of rhizoxin in advanced ovarian, colorectal and renal cancerD J Kerr, G J Rustin, S B Kaye, et al.
Cornea|January 1, 1997
Histopathology and molecular cytogenetics of a corneal opacity associated with the trisomy 8 mosaic syndrome (46,XY/47,XY, +8)J A Scott, P J Howard, P A Smith, et al.
The British Journal of Ophthalmology|June 6, 2000
Human herpesviruses in the corneaS B Kaye, K Baker, R Bonshek, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Relationship between the pharmacokinetics and toxicity of mitozolomideD J Kerr, J A Slack, P Secrett, et al.
Pageof 42

Showing results (261-270 of 411) with videos related to

Sort By:
Pageof 42
British Journal of Cancer|August 17, 2000
Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT)J S de Bono, J Paul, A Simpson, et al.
Biochemical Pharmacology|January 20, 1994
Identification of a multidrug resistance modulator with clinical potential by analysis of synergistic activity in vitro, toxicity in vivo and growth delay in a solid human tumour xenograftJ A Plumb, G C Wishart, A Setanoians, et al.
British Journal of Cancer|April 17, 1999
In pursuit of excellence for patients with cancer: the Scottish Cancer Therapy Network modelP L Stroner, D H Brewster, J A Dewar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1992
Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working PartyG Read, S P Stenning, M H Cullen, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1988
Pharmacokinetics of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum IV (iproplatinum, CHIP) in patients with normal and impaired renal function and following intraperitoneal administrationD J Kerr, M Harding, J G Farmer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1992
High-dose epirubicin in chemotherapy refractory non-seminomatous germ cell cancer: a phase II study. EORTC Genito-Urinary Tract Cancer Co-operative Group. EORTC Early Clinical Trials GroupG Stoter, A Akdas, S D Fosså, et al.
British Journal of Cancer|November 1, 1995
Phase II trials of rhizoxin in advanced ovarian, colorectal and renal cancerD J Kerr, G J Rustin, S B Kaye, et al.
Cornea|January 1, 1997
Histopathology and molecular cytogenetics of a corneal opacity associated with the trisomy 8 mosaic syndrome (46,XY/47,XY, +8)J A Scott, P J Howard, P A Smith, et al.
The British Journal of Ophthalmology|June 6, 2000
Human herpesviruses in the corneaS B Kaye, K Baker, R Bonshek, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Relationship between the pharmacokinetics and toxicity of mitozolomideD J Kerr, J A Slack, P Secrett, et al.
Pageof 42